Skip to main content

Table 1 Clinical characteristics of the 12 lung cancer patients

From: Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

Patient

Sex

Age

Histology

Stagea

KPS

Induction chemotherapy

Concurrent chemotherapy

1

F

51

small cell lung cancer

IIIa

T1N2M0

80

CE

No

2

F

50

Adenocarcinoma

IIIb

T2N3M0

80

No

PC

3

M

54

Squamous cell carcinoma

IIIa

T3N2M0

80

No

EP

4

M

48

small cell lung cancer

IIIa

T2N2M0

80

CE

No

5

F

59

Adenocarcinoma

IIIb

T3N3M0

80

NP

No

6

M

49

Squamous cell carcinoma

IIIa

T3N2M0

80

PC

EP

7

M

58

Squamous cell carcinoma

IIIa

T2N2M0

80

No

EP

8

F

63

Adenocarcinoma

IIIa

T2N2M0

80

No

PC

9

M

44

Squamous cell carcinoma

IIIb

T4N0M0

80

No

PC

10

F

41

Adenocarcinoma

IIIb

T4N2M0

80

No

EP

11

M

46

small cell lung cancer

IIIa

T2N2M0

80

EP

No

12

M

66

Squamous cell carcinoma

IIIa

T2N2M0

80

No

No

  1. KPS indicates Karnofsky performance status; CE, carboplatin, etoposide; NP, navelbine, cisplatin; PC, Paclitaxel, carboplatin; EP, etoposide, cisplatin.
  2. a Grading determined according to the American Joint Committee on Cancer 6th edition grading system.